2008
October–December
Antares Pharma and
Population Council Announce Initiation of Phase II Clinical Trial for a
Novel Contraceptive ATD™ Gel
First Transdermal Contraceptive Gel Containing Nestorone® (24 November)
Population Council Scientist
Receives Recognition for Her Research on Progestogen
(22 October)
July–September
Planned Parenthood Federation
of America Honors Distinguished Reproductive Health Scientist Irving
Sivin (23 September)The Population Council and Sheldon
Segal to be Awarded Prix Galien USA
The Pro Bono Humanum Award recognizes the Council and Segal for
their role in developing implantable hormone delivery systems. (23
September)
New Male Circumcision Device
for HIV Prevention Studied
Population Council senior scientist Marc Goldstein to head trial (1
August)
Dr. Marc Goldstein Named
the Matthew P. Hardy Distinguished Professor of Reproductive
Medicine and Urology Renowned pioneer in microsurgery and
male infertility has innovated numerous surgical techniques (31
July)
April–June
New Trustees Join Council Board
Justin Rockefeller, a youth-civic-engagement activist, and Anna
Mastroianni, a legal scholar and bioethicist, are the Council's
newest trustees.
(16 July)
Has the HIV Epidemic Peaked?
The Council's John Bongaarts is the lead author on an article in the
peer-reviewed Population and Development Review. The main
finding of this analysis is that the HIV epidemic reached a major
turning point over the past decade. (26 June)
January–March
Council Selects Louise Pedneault
as Clinical Director, Microbicides, HIV and AIDS Program (15
April)
Latest Population Council Research Findings
to Be Presented at Population Association of America Annual Meeting
News from all of the Council’s research programs will be shared at PAA's
annual meeting. (10 April)
Population Council Names Scott Newman Chief Financial Officer (3 April)
Population, Human Capital Accumulation,
and Productivity Growth
A new supplement to the Population Council's journal Population and
Development Review explores the economic consequences of the aging
of the global workforce. (2 April)
Trial Shows Anti-HIV Microbicide Is
Safe, but Does Not Prove It Effective
The results of the Phase 3 Carraguard® trial have been
announced. The trial did not show that Carraguard is effective in preventing
HIV transmission during vaginal sex, but it was shown to be safe for use
during vaginal sex over a two-year period. (18 February)
